Literature DB >> 10155332

A UK national prescribing list?

T Walley.   

Abstract

Mesh:

Year:  1995        PMID: 10155332     DOI: 10.2165/00019053-199507060-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  7 in total

1.  The UK indicative prescribing scheme: background and operation.

Authors:  J Bligh; T Walley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

2.  A review of limited lists and formularies: are they cost-effective?

Authors:  M J Pearce; E J Begg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 3.  Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding.

Authors:  T Walley; R Wilson; J Bligh
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

4.  How do doctors and patients react to the introduction of a practice formulary?

Authors:  J Field
Journal:  Fam Pract       Date:  1989-06       Impact factor: 2.267

5.  General practitioners' attitudes towards the limited list.

Authors:  A Reilly; R J Taylor; J Webster
Journal:  J R Coll Gen Pract       Date:  1986-04

6.  Controlling the NHS drugs budget. Recommendations may not help.

Authors:  C M Harris
Journal:  BMJ       Date:  1994-09-17

7.  Limited lists of drugs: lessons from abroad.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16
  7 in total
  4 in total

1.  Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?

Authors:  M Duerden; T Walley
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 3.  Drug rationing in the UK National Health Service. Current status and future prospects.

Authors:  T Walley; A Haycox; S Barton
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

4.  The UK pharmaceutical market. An overview.

Authors:  A Towse
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.